Reports
Reports
The global immunofluorescence assay market attained a value of about USD 2.7 billion in 2021. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 5.40% to reach nearly USD 3.7 billion by 2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America accounts for a significant share of the the immunofluorescence assays industry owing to the increasing incidences of chronic and infectious diseases. The increasing spending on research and development (R&D), the introduction of various favourable government initiatives, and the surging presence of major key players in the region are augmenting the market growth. The increasing automation of laboratories, the improving technology, and favourable reimbursement scenarios are increasing the demand for immunofluorescence assays, which is providing impetus to the growth of the market. With the growing deployment of immunofluorescence assays in the detection of viral antigens, in the wake of the COVID-19 pandemic, the market is witnessing robust growth.
Immunofluorescence assay is a staining or visualisation technique that is used to identify the existence of antibodies by their specific ability to react with viral antigens expressed in infected cells. In the technique, bound antibodies are visualised by incubation with fluorescently labelled anti-human antibodies and only specific cells are stained. Immunofluorescence assay can be used to analyse the distribution of proteins, glycans, and small biological and non-biological molecules. It is widely used in biological research and medical research.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major products of immunofluorescence assay are:
On the basis of types, the market can be classified into:
The market can be broadly categorised on the basis of applications into:
The EMR report looks into the regional markets of immunofluorescence assay like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing incidences of chronic diseases like intestinal cancer, HIV AIDS, Alzheimer’s, diverticulitis, Crohn’s Disease, ulcerative colitis, and inflammatory bowel disease, among others, is driving the market growth of immunofluorescence assay. The rising availability of advanced kits and reagents and the increasing application of immunofluorescence assays in diagnostic and research studies are also accelerating market growth.
The surging research and development (R&D) activities for technological advancements and the increasing investments by governments in healthcare are expected to bolster the demand for immunofluorescence assays, which is estimated to propel the market growth. The increasing demand for robust healthcare facilities, the rising focus on antibody waste, therapeutics and several preclinical and clinical studies are predicted to fuel the market growth in the forecast period.
The report presents a detailed analysis of the following key players in the global immunofluorescence assay market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Type, Application, Region |
Breakup by Product | Reagents and Kits, Instruments, Consumables and Accessories |
Breakup by Type | Indirect Immunofluorescence, Direct Immunofluorescence |
Breakup by Application | Cancer, Infectious Diseases, Autoimmune Diseases, Others |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Thermo Fisher Scientific Inc., Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., Sino Biological Inc., PerkinElmer Inc., Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Immunofluorescence Assay Market Analysis
8.1 Key Industry Highlights
8.2 Global Immunofluorescence Assay Historical Market (2018-2022)
8.3 Global Immunofluorescence Assay Market Forecast (2023-2028)
8.4 Global Immunofluorescence Assay Market by Product
8.4.1 Reagents and Kits
8.4.1.1 Historical Trend (2018-2022)
8.4.1.2 Forecast Trend (2023-2028)
8.4.2 Instruments
8.4.2.1 Historical Trend (2018-2022)
8.4.2.2 Forecast Trend (2023-2028)
8.4.3 Consumables and Accessories
8.4.3.1 Historical Trend (2018-2022)
8.4.3.2 Forecast Trend (2023-2028)
8.5 Global Immunofluorescence Assay Market by Type
8.5.1 Indirect Immunofluorescence
8.5.1.1 Historical Trend (2018-2022)
8.5.1.2 Forecast Trend (2023-2028)
8.5.2 Direct Immunofluorescence
8.5.2.1 Historical Trend (2018-2022)
8.5.2.2 Forecast Trend (2023-2028)
8.6 Global Immunofluorescence Assay Market by Application
8.6.1 Cancer
8.6.1.1 Historical Trend (2018-2022)
8.6.1.2 Forecast Trend (2023-2028)
8.6.2 Infectious Diseases
8.6.2.1 Historical Trend (2018-2022)
8.6.2.2 Forecast Trend (2023-2028)
8.6.3 Autoimmune Diseases
8.6.3.1 Historical Trend (2018-2022)
8.6.3.2 Forecast Trend (2023-2028)
8.6.4 Others
8.7 Global Immunofluorescence Assay Market by Region
8.7.1 North America
8.7.1.1 Historical Trend (2018-2022)
8.7.1.2 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Historical Trend (2018-2022)
8.7.2.2 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Historical Trend (2018-2022)
8.7.3.2 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Historical Trend (2018-2022)
8.7.4.2 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Historical Trend (2018-2022)
8.7.5.2 Forecast Trend (2023-2028)
9 North America Immunofluorescence Assay Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
10 Europe Immunofluorescence Assay Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2022)
10.1.2 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Historical Trend (2018-2022)
10.2.2 Forecast Trend (2023-2028)
10.3 France
10.3.1 Historical Trend (2018-2022)
10.3.2 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Historical Trend (2018-2022)
10.4.2 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Immunofluorescence Assay Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2022)
11.1.2 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Historical Trend (2018-2022)
11.2.2 Forecast Trend (2023-2028)
11.3 India
11.3.1 Historical Trend (2018-2022)
11.3.2 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Historical Trend (2018-2022)
11.4.2 Forecast Trend (2023-2028)
11.5 Australia
11.5.2 Historical Trend (2018-2022)
11.5.2 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Immunofluorescence Assay Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2022)
12.1.2 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Historical Trend (2018-2022)
12.2.2 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Historical Trend (2018-2022)
12.3.2 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Immunofluorescence Assay Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2022)
13.1.2 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2022)
13.2.2 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Historical Trend (2018-2022)
13.3.2 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Historical Trend (2018-2022)
13.4.2 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Thermo Fisher Scientific Inc.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Cell Signaling Technology, Inc.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Bio-Rad Laboratories, Inc.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Sino Biological Inc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 PerkinElmer Inc.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Immunofluorescence Assay Market: Key Industry Highlights, 2018 and 2028
2. Global Immunofluorescence Assay Historical Market: Breakup by Product (USD Billion), 2018-2022
3. Global Immunofluorescence Assay Market Forecast: Breakup by Product (USD Billion), 2023-2028
4. Global Immunofluorescence Assay Historical Market: Breakup by Type (USD Billion), 2018-2022
5. Global Immunofluorescence Assay Market Forecast: Breakup by Type (USD Billion), 2023-2028
6. Global Immunofluorescence Assay Historical Market: Breakup by Application (USD Billion), 2018-2022
7. Global Immunofluorescence Assay Market Forecast: Breakup by Application (USD Billion), 2023-2028
8. Global Immunofluorescence Assay Historical Market: Breakup by Region (USD Billion), 2018-2022
9. Global Immunofluorescence Assay Market Forecast: Breakup by Region (USD Billion), 2023-2028
10. North America Immunofluorescence Assay Historical Market: Breakup by Country (USD Billion), 2018-2022
11. North America Immunofluorescence Assay Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Europe Immunofluorescence Assay Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Europe Immunofluorescence Assay Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Asia Pacific Immunofluorescence Assay Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Asia Pacific Immunofluorescence Assay Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Latin America Immunofluorescence Assay Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Latin America Immunofluorescence Assay Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Middle East and Africa Immunofluorescence Assay Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Middle East and Africa Immunofluorescence Assay Market Forecast: Breakup by Country (USD Billion), 2023-2028
20. Global Immunofluorescence Assay Market Structure
In 2021, the global immunofluorescence assay market attained a value of nearly USD 2.7 billion.
The market is projected to grow at a CAGR of 5.40% between 2023 and 2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach about USD 3.7 billion by 2027.
The market is being propelled by the rising incidences of chronic and infectious diseases, the increasing automation of laboratories, and the growing deployment of immunofluorescence assays in the detection of viral antigens.
The increasing investments in the research and development (R&D), the rising availability of advanced kits and reagents, and the increasing applications of immunofluorescence assays in diagnostics and research activities are anticipated to drive the market growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Reagents and kits, instruments, and consumables and accessories are the various products of immunofluorescence assay in the industry.
The major types of immunofluorescence assay in the industry are indirect immunofluorescence and direct immunofluorescence.
Cancer, infectious diseases, and autoimmune diseases, among others, are the significant applications of immunofluorescence assay.
The major players in the industry are Thermo Fisher Scientific Inc., Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., Sino Biological Inc. and PerkinElmer Inc., among others.
The global immunofluorescence assay market attained a value of nearly USD 2.7 billion in 2021, driven by the rising spending on research and development. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 5.40%. The market is projected to reach about USD 3.7 billion by 2027.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of its products, the immunofluorescence assay industry can be divided into reagents and kits, instruments, and consumables and accessories. Based on types, the market can be segmented into indirect immunofluorescence and direct immunofluorescence. On the basis of application, the market is segmented into cancer, infectious diseases, and autoimmune diseases. The major regional markets for immunofluorescence assay are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Thermo Fisher Scientific Inc., Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., Sino Biological Inc. and PerkinElmer Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.